05:46 PM EDT, 05/22/2025 (MT Newswires) -- Outlook Therapeutics ( OTLK ) shares fell 21% in recent after-hours trading Thursday after the company announced plans for a public offering of shares and accompanying warrants,
Proceeds are expected to be for working capital and general corporate purposes, the company said Thursday in a statement.